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WHAT IS YOUR DIAGNOSIS
A female neonate was born by cesarean section at 29 weeks of gestation. Five days before delivery, premature membrane rupture occurred. 
At 25 weeks of gestation, Candida albicans was identified in maternal vaginal exudate. On the second day of life, widespread skin eruptions 
were noticed during physical examination. No other symptoms were observed. Blood panel revealed leukemoid reaction (56,990 leukocytes/
μL) with negative c-reactive protein. Urine and blood cultures were negative. Collaboration of Department of Dermatology was requested at 
this point and microbiological lesion examination was performed. 
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What is your diagnosis?
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prevent dissemination and decrease mortality risk.
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RESUMO
A candidíase cutânea congénita é uma doença rara causada por 
infeção intrauterina por Candida. Manifesta-se nos primeiros seis 
dias de vida com surgimento de exantema difuso. O diagnóstico pode 
ser confirmado por exame microbiológico da pele. Deve ser iniciada 
terapêutica empírica com antifúngico sistémico no momento da 
apresentação, sobretudo em recém-nascidos pré-termo, de modo a 
evitar a disseminação e diminuir o risco de mortalidade.  
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DIAGNOSIS
Congenital cutaneous candidiasis
DISCUSSION
Candida skin infections are common during neonatal period.1 
However, congenital cutaneous candidiasis (CCC) is a rare disease, 
with less than 100 cases published in the medical literature.1,2 
Reported in term and preterm infants, CCC is acquired in utero 
via ascending Candida infection.3 In the present case, lesion 
microbiological examination identified Candida albicans, which was 
also subsequently detected in placenta microbiological examination. 
The patient was treated with fluconazole during 14 days, with clinical 
improvement.
Despite the high incidence of Candida albicans vaginal infection 
during pregnancy (around 20−25%), only less than 1% of cases 
develop chorioamnionitis − believed to be the underlying mechanism 
of fetal infection −, even though the exact etiopathogenesis remains 
unknown.1,2
Contrarily to acquired cutaneous candidiasis, in which skin lesions 
appear after the first week of life, CCC often presents within the first 
six days.1,3 Clinical presentation is variable and may include erythema, 
pustules, and exfoliation or desquamation, and skin involvement is 
diffuse.4 Typically, no analytic alterations are found. Diagnosis can be 
confirmed by microscopic examination and cutaneous lesion culture.2
Empiric systemic antifungal therapy should be promptly started 
at the time of skin lesion presentation and maintained for at least 
14 days to prevent dissemination and decrease mortality risk.4 
Antifungal agent choice (amphotericin B or fluconazole) remains 
controversial and requires further research.2
Congenital candidiasis can cause a variety of clinical features, 
ranging from diffuse erythematous skin eruption to systemic disease, 
with mortality potentially reaching 40% in the latter.2,4 Although all 
infants are at risk of disseminated disease, preterms have a higher 
risk due to their immature and compromised mucocutaneous barrier 
and systemic defenses.1
With this case, the authors aim to raise awareness to CCC, a rare 
disease in which prompt recognition and early antifungal treatment 
are paramount for adequate infant management.
ABSTRACT
Congenital cutaneous candidiasis is a rare disease acquired in utero 
via ascending Candida infection. Skin involvement is diffuse and 
often appears in the first six days of life. Diagnosis can be confirmed 
by microscopic examination and cutaneous lesion culture. Empiric 
therapy with systemic antifungal should be promptly started at the 
time of cutaneous manifestations, specially in preterm infants, to 
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